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Abst rac t
Background and purpose: The aim of this study was to per-
form a validation analysis of the Polish adaptation of the Mul-
tiple Sclerosis International Quality of Life Questionnaire,
MusiQoL. 
Material and methods: Validation analysis included the trans-
lation of the original English version into Polish according
to translation principles and the analysis of convergent 
validity, internal reliability and reproducibility of the Polish
version of MusiQoL. The study included 150 randomly
chosen patients (109 women and 41 men) with definite mul-
tiple sclerosis (MS) diagnosed according to McDonald cri-
teria. Mean age of patients was 41 ± 10 years and mean
disease duration was 11.7 ± 7.2 years. The patients com-
pleted the examined MusiQoL, the Functional Assessment
of Multiple Sclero sis (FAMS) and the Multiple Sclerosis
Impact Scale (MSIS-29). Data regarding sociodemographic
status and MS history were collected. The disability of the
patients was assessed according to the Expanded Disability
Status Scale (EDSS). The examination was repeated after
28 ± 4 days.
Results: The internal reliability, convergent validity and repro-
ducibility of MusiQoL were satisfactory. The dimensions of
the scale exhibited high internal consistency (Cronbach’s alpha
from 0.67 to 0.90). The MusiQoL correlated with FAMS
(positive correlations), EDSS and MSIS-29 (negatively).
Validation analysis of the Polish version of the Multiple Sclerosis International
Quality of Life Questionnaire (MusiQoL)
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St reszczenie  
Wstêp i cel pracy: Celem pracy by³a analiza walidacyjna aspek-
tów psychometrycznych polskiej adaptacji Miêdzynarodo-
wego kwestionariusza jakoœci ¿ycia w stwardnieniu rozsianym
(SR) – Multiple Sclerosis International Quality of Life Question-
naire, MusiQoL.
Materia³ i metody: Analiza walidacyjna objê³a t³umaczenie
oryginalnej wersji angielskiej na jêzyk polski zgodnie z obo-
wi¹zuj¹cymi zasadami translacyjnymi oraz analizê aspektów
trafnoœci i rzetelnoœci skali MusiQoL. Do badañ w³¹czono
150 losowo wybranych pacjentów z rozpoznaniem SR wed³ug
kryteriów McDonalda (109 kobiet i 41 mê¿czyzn). Œrednia
wieku badanych wynosi³a 41 ± 10 lat, œredni czas trwania
choroby – 11,7 ± 7,2 roku. Pacjenci wype³niali badany kwe-
stionariusz MusiQoL, Kwestionariusz do Oceny Jakoœci ¯ycia
w Stwardnieniu Rozsianym (FAMS) oraz Skalê Wp³ywu
Stwardnienia Rozsianego na Jakoœæ ¯ycia Chorych (MSIS-29).
Zebrano dane spo³eczno-demograficzne pacjentów i dotycz¹ce
historii przebiegu choroby. U wszystkich oceniono ponadto
stopieñ niesprawnoœci na podstawie Rozszerzonej Skali Nie-
wydolnoœci Ruchowej (EDSS). Badania przeprowadzono
w dniu 0, a nastêpnie powtórzono po 28 ± 4 dniach.
Wyniki: Rzetelnoœæ i badane aspekty trafnoœci polskiej 
wersji skali MusiQoL s¹ zadowalaj¹ce. Wykazano równie¿
powtarzalnoœæ wyników badanej skali oraz du¿¹ spójnoœæ
wewnêtrzn¹ poszczególnych podskal (wspó³czynnik alfa Cron-
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Introduction
The assessment of quality of life in chronic progres-
sive disease, such as multiple sclerosis (MS), is very
important for the monitoring of patients’ health status
and for the evaluation of treatment efficacy. Currently,
we may choose among about 20 questionnaires, includ -
ing several self-reported measures, used to assess
the health status of patients with MS. In 2008, Simeoni
et al. in close collaboration with neurologists from 
15 countries (Argentina, Canada, France, Germany,
Greece, Israel, Italy, Lebanon, Norway, Russia, South
Africa, Spain, Turkey, United Kingdom, and USA) 
proposed a new scale – the Multiple Sclerosis Interna-
tional Quality of Life Questionnaire (MusiQoL) [1].
This scale reflects specifically the point of view of MS
patients on the impact of the disease on their everyday
life and evaluates multiple dimensions of patients’ life.
MusiQoL was developed after interviews with patients,
and its international validation was made in a group of
1992 patients [1].
Polish neurologists have quite a limited choice of
questionnaires related to quality of life in MS that have
been validated and culturally adapted; these include
Functional Assessment of Multiple Sclerosis (FAMS)
[2], Multiple Sclerosis Impact Scale 29 (MSIS-29)
[3], Modified Fatigue Impact Scale (MFIS) [4], and
Multiple Sclerosis Quality of Life-54 Instrument
(MSQOL-54) [5]. We aimed, therefore, to perform
validation analysis of psychometric properties of the
Polish adaptation of MusiQoL.
The MusiQoL scale contains 31 items divided into
9 dimensions: activity of daily living (ADL, eight items);
psychological well-being (PWB, four items); symptoms
(SPT, three items); relationships with friends (RFr, four
items); family relationships (RFa, three items); satis-
faction with health care system (RHCS, three items);
sentimental and sexual life (SSL, two items); coping
(COP, two items) and rejection (REJ, two items).
The total MusiQoL score ranges between 0 and
100; lower scores indicate a worse quality of life. The Po -
lish version of MusiQoL can be found in the appendix
to this paper.
Material and methods
The study included 150 randomly chosen patients
diagnosed with multiple sclerosis according to McDo-
nald criteria [6] who visited an out-patient Neurologi-
cal Clinic or were admitted to the Department of Neu-
rology (both institutions in Self-Dependent Public
Teaching Hospital No. 4 in Lublin) between Decem-
ber 2008 and May 2010. All patients were adults at 
the time of examination. Each patient provided written
informed consent to participate in the study. The Bio-
ethical Committee of Lublin Medical University appro-
ved the protocol of the study.
Language adaptation of the MusiQoL scale was
done according to the guidelines [7,8]. Two indepen-
dent translators, Polish native-speakers, provided the
translation of the original English scale into Polish (for-
ward translation). Each item of both translations was
analysed and compared with the other version, and the
most accurate version of each controversial item was
established. Then, the backward translation was per-
formed. It did not reveal any errors of the established
proposal when compared with the original version.
A neurologist with expertise in MS assessed the trans-
lation in relation to the accuracy of the medical terms.
The proposed version was used for preliminary testing
in 20 patients with MS (10 women and 10 men) who
represented different sociodemographic characteristics.
Patients provided positive feedback in relation to the
understanding of each question, the terminology used,
length of questions, usefulness and emotions associated
with answering the questions. After the positive opinion,
the final version was used in validation analysis.
bacha od 0,67 do 0,90). Stwierdzono korelacje skali MusiQoL
ze skal¹ FAMS (korelacje dodatnie), EDSS i MSIS-29
(korelacje ujemne).
Wnioski: Analiza psychometryczno-statystyczna wykaza³a,
¿e polska wersja skali MusiQoL jest wartoœciowym
narzêdziem do badania wp³ywu choroby na jakoœæ ¿ycia pol-
skich chorych na SR.
S³owa kluczowe: stwardnienie rozsiane, analiza walidacyjna,
MusiQoL.
Conclusions: Psychometric-statistical analysis showed that
the Polish version of MusiQoL is a valuable measure to exa-
mine the health-related quality of life of Polish MS patients.
Key words: multiple sclerosis, validation analysis, MusiQoL.
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Validation analysis of MusiQoL scale
Before testing, each patient was examined with the
Mini Mental State Examination (MMSE) to exclude
those with cognitive disturbances; only patients who 
scored at least 28 points in the MMSE were included
in the study [9]. Patients during relapse and those un -
able to complete the questionnaire without help were
also excluded.
Patients were tested twice: at baseline and after an
interval of 28 ± 4 days. Each subject was asked to 
complete the questionnaires related to the assessment 
of the severity of particular symptoms and quality of 
life. Questionnaires included FAMS, MSIS-29 and 
MusiQoL. FAMS and MSIS-29 were chosen as com-
parators because Polish versions are available and vali-
dated [2,3].
Patients were examined by two neurologists and 
the severity of the patient’s disability was assessed with
the Expanded Disability Status Scale (EDSS) [10]. To
avoid inter-rater discrepancies, each patient was exami-
ned by the same neurologist. 
Results were characterized with means and standard
deviations. Reliability of the MusiQoL scale was tested
with the internal consistency provided by Cronbach’s
alpha coefficient. Construct validity of the scale was
assessed by the analysis of the results obtained with
MusiQoL in correlation with the duration of the dise-
ase and with tests that measure similar features (EDSS,
FAMS, and MSIS-29), i.e. convergent validity. Diffe-
rences between subgroups were also analysed to address
the hypothesis on different results of the scale for diffe-
rent MS types. Reproducibility of the scale was also eva-
luated. A p-value < 0.05 was considered significant.
Statistical analysis was performed with SPSS 14.0 PL
statistical package.
Results
The study comprised 150 patients with MS, includ-
ing 109 women (73%) and 41 men (27%). Their age
ranged between 21 and 66 years (mean: 41, SD: 10 years).
Eighty-seven patients (58%) lived in towns and the other
63 (42%) lived in the country. 
One hundred and four participants (70%) were mar-
ried and 46 (30%) were single or widowed. Thirty-one
patients (21%) had vocational educational, 75 patients
(50%) had secondary (general or technical) school edu-
cation, and 44 participants (29%) had a university
degree. Fifty-nine patients (39%) were employed and
91 patients (61%) received disability pension. Mean
duration of the disease was 11.7 (SD: 7.2) years (ran-
ge: 1-35). Relapsing-remitting MS was diagnosed in 
60 subjects (40%), primary progressive MS was dia-
gnosed in 17 patients (11%), and secondary progressi-
ve MS in 73 patients (49%).
Total scores in MusiQoL and the subscores in each
dimension for patients with specific MS types are pro-
vided in Table 1.
The lowest total scores in MusiQoL as well as in
ADL and PWB dimensions were obtained in patients
with primary progressive and secondary progressive
MS. The lowest score in the SPT dimension was noted
in patients with secondary progressive MS, and the
lowest score in the REJ dimension was found in patients
with primary progressive MS. No significant differen-
ces in RFr, RFa, RHCS, SSL or COP dimensions were
noted among patients with different types of MS. 
As expected, there were no significant differences
in total scores or in most of the subscores found in rela-
tion to sex (except for a lower score in the PWB dimen-
sion among women) or to marital status (except for
a higher score in the ADL dimension among single
persons).
Patients living in towns had higher scores than 
their counterparts who lived in the country in ADL
(44.5 ± 27.9 vs. 33.8 ± 26.8, p < 0.05), PWB 
(60.2 ± 22.5 vs. 48.8 ± 24.4, p < 0.05), and SPT 
(71 ± 19.5 vs. 61.7 ± 26.8, p < 0.05) but scored less
in SSL (25.8 ± 24 vs. 40.6 ± 29.9, p < 0.01). Patients
receiving disability pension had worse health-related
quality of life and had a lower total MusiQoL score
(40.4 ± 11.5 vs. 45.8 ± 14.1, p < 0.05), lower ADL
(29.6 ± 22 vs. 56 ± 28.4, p < 0.01), SPT (61.7 ± 22.7
vs. 75.4 ± 21.8, p < 0.01), and COP (46.4 ± 29.7 
vs. 57.2 ± 29, p < 0.05) subscores, and higher SSL
subscores (36.6 ± 27.5 vs. 25 ± 26.4, p < 0.01). 
Patients with a university degree had a higher total
score in MusiQoL in comparison to subjects with voca-
tional education (45.8 ± 9.9 vs. 39.8 ± 10.6, p < 0.05).
ADL dimension subscores were also higher in patients
with university education in comparison to those with
secondary (52.7 ± 29.8 vs. 36.5 ± 26.8, p < 0.05) or
vocational education (52.7 ± 29.8 vs. 30.8 ± 21.7, 
p < 0.01). Patients with a university degree had higher
scores in the SPT dimension than patients with voca-
tional education (75.2 ± 18.1 vs. 57.2 ± 24.7,
p < 0.01) and in the REJ dimension than patients with
secondary education (70.4 ± 25.4 vs. 56.8 ± 34.7, 
p < 0.05).
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Scale dimension Multiple sclerosis type Mean (SD) Range p-value
MusiQoL – total score PP 37.7 (13.9) 19-68 < 0.05 (RR vs. PP patients)
RR 47.6 (14.1) 17-99 < 0.01 (RR vs. SP patients)
SP 39.6 (10.0) 17-59
Total 42.5 (12.8) 17-99
MusiQoL – ADL PP 25.4 (15.7) 0-50 < 0.01 (RR vs. PP patients)
RR 59.8 (26.3) 3-100 < 0.01 (RR vs. SP patients)
SP 27.2 (21.1) 0-91
Total 40.1 (27.9) 0-100
MusiQoL – PWB PP 50.7 (23.4) 19-100 < 0.05 (RR vs. SP patients)
RR 62.2 (23.3) 13-100
SP 50.9 (23.6) 6-100
Total 55.4 (24.0) 6-100
MusiQoL – RFr PP 33.8 (32.1) 0-100 NS
RR 32.5 (22.5) 0-100
SP 31.8 (24.8) 0-83
Total 32.3 (24.6) 0-100
MusiQoL – SPT PP 76.1 (20.2) 44-100 < 0.05 (PP vs. SP patients)
RR 71.2 (25.0) 0-100
SP 61.6 (21.4) 13-100
Total 67.1 (23.3) 0-100
MusiQoL – RFa PP 14.2 (20.1) 0-75 NS
RR 19.6 (26.4) 0-100
SP 19.6 (21.5) 0-92
Total 19.0 (23.4) 0-100
MusiQoL – RHCS PP 20.6 (18.2) 0-67 NS
RR 24.4 (22.9) 0-100
SP 28.6 (23.2) 0-83
Total 26.1 (22.6) 0-100
MusiQoL – SSL PP 32.3 (30.6) 0-100 NS
RR 28.3 (27.4) 0-100
SP 35.1 (27.1) 0-75
Total 32.1 (27.6) 0-100
MusiQoL – COP PP 41.2 (27.2) 0-88 NS
RR 57.1 (29.8) 0-100
SP 47.6 (29.7) 0-100
Total 50.7 (29.8) 0-100
MusiQoL – REJ PP 44.8 (34.8) 0-100 < 0.05 (RR vs. PP patients)
RR 72.9 (29.0) 0-100 < 0.01 (RR vs. SP patients)
SP 53.4 (32.3) 0-100
Total 60.2 (32.9) 0-100
Table 1. MusiQoL total scores and dimension-related subscores in patients with various types of multiple sclerosis (one-way analysis of variance with post-hoc 
Dunnett test for the differences between group means)
SD – standard deviation
PP – primary progressive, RR – relapsing-remitting, SP – secondary progressive
ADL – activities of daily living, PWB – psychological well-being, SPT –  symptoms, RFr – relationships with friends, RFa – family relationships, RHCS – satisfaction with health care 
system, SSL – sentimental and sexual life, COP – coping, REJ – rejection, NS – non-significant
Neurologia i Neurochirurgia Polska 2011; 45, 3 239
Validation analysis of MusiQoL scale
Reliability
Analysis of frequency distribution
Normal distribution was noted in total MusiQoL sco-
res, and its PWB and SPT dimensions. The distribution
of scores in other dimensions and in particular items was
skewed. This was similar to the results obtained by the
authors of the original version of the scale [1].
A significant correlation (Pearson R, p < 0.01) was
found between total MusiQoL score and scores in par-
ticular dimensions.
Internal consistency of MusiQoL
Cronbach’s alpha coefficient for MusiQoL ranged
between 0.67 and 0.90 (ADL: 0.90, PWB: 0.86, RFr:
0.82, SPT: 0.76, RFa: 0.86, RHCS: 0.85, SSL: 0.67,
COP: 0.77, and REJ: 0.89). Internal consistency of 
the MusiQoL scale is therefore satisfactory, except for 
the SSL dimension.
Validity analysis
Convergent validity of MusiQoL
Total scores in MusiQoL correlated negatively with
EDSS score (p < 0.01), and correlated positively with
total FAMS score (p < 0.01) and with each FAMS
subscale (p < 0.01) except for FAMS Family/social well-
being subscale. Total scores in MusiQoL correlated
negatively also with MSIS-29 physical subscale and
MSIS-29 psychological subscale (p < 0.01). Negative
correlations were noted between EDSS and ADL,
PWB, SPT, COP, and REJ dimensions. Subscales
ADL, PWB, RFr, SPT, RHCS, SSL, COP and 
REJ correlated (positively in most cases) with total
FAMS score and with each FAMS subscale. The same
MusiQoL subscales correlated (negatively in most
cases) with MSIS-29 physical and MSIS-29 psychologi-
cal subscale. SSL subscale showed similar correlations
(with the exception of EDSS) and RHCS subscale cor-
related with similar subscales (with the exception of the
Symptoms subscale of FAMS). RFr subscale correla-
ted only with total FAMS and its subscales: Emotional
well-being, General contentment, and Additional concerns.
RFa subscale correlated only with FAMS subscales:
General contentment, Family/social well-being and Additio-
nal concerns. The correlations described above are deta-
iled in Table 2. MusiQoL score did not correlate with
duration of the disease or with patients’ age. Exceptions
were correlations between MusiQoL ADL, SSL and
REJ subscales with age as well as between MusiQoL
SSL subscale and the duration of the disease.
Reproducibility of MusiQoL scale 
(test-retest analysis)
Patients’ status did not change significantly bet ween
two tests – EDSS score did not change. A significant
correlation was noted between baseline MusiQoL score
and the assessment repeated after 4 weeks (Table 3). 
No difference was noted between particular items bet -
ween day 0 and day 28. These results suggest reprodu-
cibility of the test. 
Mean time required for completion of the question-
naire was 12.5 ± 10 minutes. The percentage of mis-
sing data was small, with the exception of the SSL sub-
scale (16%).
Discussion
This study showed satisfactory results of tested relia-
bility, validity and reproducibility of the Polish version
of MusiQoL. This scale correlates with other scales
(FAMS and MSIS-29) commonly used to assess phy-
sical and emotional status of patients.
Correlations were found between MusiQoL dimen-
sions related to activities of daily living, symptoms and
psychological well-being and with the EDSS subscale
that describes the degree of patient’s disability. It might
be inferred that EDSS does not reflect fully the quality
of life among patients. It was found, paradoxically, that
the duration of the disease has no influence on patients’
quality of life. Similar results were obtained during the
validation of the international version of MusiQoL [1];
the same finding was reported also in earlier studies on
MS [1,3] and schizophrenia [1]. Lack of worsening
in terms of quality of life in relation to the duration of
disease may be explained by the heterogeneous course
of the disease or presence of the benign form of MS that
occurs in 15-20% of MS patients in whom the EDSS
score is < 3 after at least 15 years of the disease [11].
The higher MusiQoL scores in patients with relap-
sing-remitting MS suggest their better quality of life
while the lower MusiQoL scores in patients with pri-
mary or secondary progressive MS point to a worse
quality of life due to the more advanced disease.
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Validation analysis of MusiQoL scale
The lower scores of patients living in the country in
dimensions related to activities of daily living, symptoms
and psychological well-being suggest that their quality
of life is worse than in their counterparts living in the
town, possibly due to the worse access to specialized
health care and to the modern methods of treatment or
in association with their more demanding living condi-
tions in general. Higher ADL and SPT subscores in
employed patients, as well as in the COP subscore, ful-
fil the expectations related to the scale.
Patients with a university degree, who scored higher
in total MusiQoL and in its ADL, SPT and REJ
dimensions have better quality of life related to activi-
ties of daily living, cope better with their symptoms and
experience less social rejection in comparison with
patients with vocational or secondary education.
Validation analysis shows that MusiQoL is useful
for the assessment of the impact of the disease on quali-
ty of life in MS patients. The obtained correlation coef-
ficients between MusiQoL and related measures sug-
gest a satisfactory convergent validity of the MusiQoL
scale. The reproducibility of MusiQoL is another posi-
tive feature that proves its reliability. MusiQoL is rela-
tively brief and takes a short time to complete (12.5 ±
10 minutes). The scale may be used for both clinical and
research purposes, as well as a tool for monitoring pa -
tients’ health status. The prognostic utility of MusiQoL
might also be considered.
Conclusions
1. Validation analysis of MusiQoL showed that the sca-
le is a useful self-reporting tool for the assessment of
patients with MS.
2. The relatively small group (n = 150) and the limited
number of methods chosen for statistical analysis
require further studies with larger samples.
Mean Standard Standard error Correlation 
deviation of the mean coefficient
Pair 1 MusiQoL – total (day 0) 42.8 13.1 1.1
0.711
MusiQoL – total (day 28) 44.5 12.8 1.1
Pair 2 Musi – ADL (day 0) 41.2 28.1 2.4
0.872
Musi – ADL (day 28) 41.4 30.1 2.6
Pair 3 Musi – PWB (day 0) 55.7 24.2 2.1
0.646
Musi – PWB (day 28) 55.9 27.0 2.3
Pair 4 Musi – RFr (day 0) 31.6 23.5 2.0
0.541
Musi – RFr (day 28) 35.2 21.8 1.9
Pair 5 Musi – SPT (day 0) 68.4 23.6 2.1
0.608
Musi – SPT (day 28) 71.4 21.8 1.9
Pair 6 Musi – RFa (day 0) 18.9 23.7 2.1
0.547
Musi – RFa (day 28) 21.8 21.8 1.9
Pair 7 Musi – RHCS (day 0) 26.0 22.6 2.0
0.564
Musi – RHCS (day 28) 28.1 21.7 1.9
Pair 8 Musi – SSL (day 0) 30.7 27.4 2.4
0.634
Musi – SSL (day 28) 33.6 27.2 2.4
Pair 9 Musi – COP (day 0) 51.3 30.1 2.6
0.571
Musi – COP (day 28) 53.1 30.0 2.6
Pair 10 Musi – REJ (day 0) 61.5 33.4 2.9
0.654
Musi – REJ (day 28) 60.3 32.5 2.8
Table 3. Test-retest analysis for the assessment with MusiQoL on day 0 (MusiQoL) and day 28 (statistics for paired samples; p < 0.001 for all correlations)
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Validation analysis of MusiQoL scale
Z powodu SR, w czasie ostatnich 4 tygodni, czy Pan/i
Na ka¿de pytanie, proszê zaznaczyæ odpowiedŸ najbli¿sz¹ Nigdy/ Rzadko/ Czasami/ Czêsto/ Zawsze/ Nie
Pani/Pana odczuciom Wcale nie Trochê Nieco Du¿o Bardzo du¿o dotyczy
1) mia³/a problemy z chodzeniem lub poruszaniem siê 
poza domem?
2) mia³/a problemy z zajêciami poza domem,  
tj. z zakupami, wyjœciem do kina itp.?
3) mia³/a problemy z chodzeniem lub poruszaniem siê po domu?
4) mia³/a problemy z równowag¹ lub chodzeniem?
5) mia³/a problemy z prac¹ w domu w czasie wolnym, 
tj. majsterkowaniem, uprawianiem ogrodu itp.?
6) mia³/a problemy z prac¹ zawodow¹, tj. z integracj¹ 
(ze wspó³pracownikami), wspó³prac¹ z innymi 
(z powodu swojej choroby), ograniczeniami
(spowodowanymi chorob¹)?
7) szybko siê mêczy³/a?
8) nie mia³/a energii?
9) czu³/a siê zaniepokojona/y?
10) czu³/a siê w depresji lub przygnêbiona/y?
11) Pani/Panu chcia³o siê p³akaæ?
12) czu³/a siê zdenerwowana/y lub poirytowana/y
przez niektóre rzeczy lub sytuacje?
13) mia³/a problemy z powodu utraty pamiêci? 
14) mia³/a k³opoty z koncentracj¹, tj. podczas czytania, 
ogl¹dania filmu, w pod¹¿aniu za dyskusj¹?
15) mia³/a problemy z powodu pogorszenia wzroku 
lub innych zaburzeñ widzenia?
16) doœwiadcza³/a nieprzyjemnych uczuæ, tj. gor¹ca, zimna…?
17) rozmawia³/a ze swoimi przyjació³mi?
18) czu³/a siê rozumiana/y przez przyjació³?
19) czu³/a siê wspierana/y przez przyjació³?
20) rozmawia³/a z ma³¿onkiem/partnerem lub rodzin¹?
21) czu³/a siê rozumiana przez ma³¿onka/partnera 
lub rodzinê?
22) czu³/a siê wspierana/y przez swojego ma³¿onka/partnera lub 
swoj¹ rodzinê?
23) czu³/a siê usatysfakcjonowana/y swoim ¿yciem uczuciowym?
24) czu³/a siê usatysfakcjonowana/y swoim ¿yciem erotycznym?
25) czu³/a, ¿e Pani/Pana sytuacja jest niesprawiedliwa?
26) czu³/a siê rozgoryczona/y?
Appendix
Multiple Sclerosis International Quality of Life Questionnaire (Polish version)
Miêdzynarodowy Kwestionariusz Jakoœci ¯ycia w Stwardnieniu Rozsianym (SR): MusiQol
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27) by³/a zdenerwowana/y z powodu spojrzeñ innych ludzi?
28) by³/a zak³opotana/y publicznie?
29) by³/a usatysfakcjonowana/y informacjami dotycz¹cymi
Pani/Pana choroby lub jej leczenia udzielanymi przez lekarzy,
pielêgniarki, psychologów itp. zajmuj¹cych siê Pani/Pana SR?
30) czu³/a siê Pan/i rozumiana/y przez lekarzy, pielêgniarki,
psychologów itp. zajmuj¹cych siê Pani/Pana SR?
31) by³/a usatysfakcjonowana/y swoim leczeniem?
